<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Toxic Dolls | Axelsen Levy | Activity</title>
	<link>https://toxicdolls.com/members/cowglass2/activity/</link>
	<atom:link href="https://toxicdolls.com/members/cowglass2/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Axelsen Levy.</description>
	<lastBuildDate>Fri, 15 May 2026 11:23:47 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">61bb8aecb5cdaaf0b3b25937eeaeda7d</guid>
				<title>Axelsen Levy posted an update: Primary nitinol stenting (PNS) and drug-coated balloon (DCB) [&#133;]</title>
				<link>https://toxicdolls.com/activity-2/p/13916/</link>
				<pubDate>Sun, 29 Jun 2025 07:39:42 +0000</pubDate>

									<content:encoded><![CDATA[<p>Primary nitinol stenting (PNS) and drug-coated balloon (DCB) angioplasty are two of the most common endovascular interventions for femoropopliteal atherosclerotic disease. Although many prospective randomized controlled trials have compared PNS or DCB with plain balloon angioplasty (POBA), no studies have directly compared PNS against DCB therapy.&hellip;<span class="activity-read-more" id="activity-read-more-13916"><a href="https://toxicdolls.com/activity-2/p/13916/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">6655434227b3f69b19b24fccda7a4754</guid>
				<title>Axelsen Levy posted an update: Contrarily, overexpression of PARK7 in CD133- non-GSCs [&#133;]</title>
				<link>https://toxicdolls.com/activity-2/p/9311/</link>
				<pubDate>Mon, 23 Jun 2025 22:19:53 +0000</pubDate>

									<content:encoded><![CDATA[<p>Contrarily, overexpression of PARK7 in CD133- non-GSCs increased self-renewal activities, migration, and IR resistance, and rescued the reduction of GSC factors under shPARK7-transfected and serum-differentiation conditions. Intriguingly, PARK7 acted as a co-chaperone of HSP90 by binding to it, protecting EGFRvIII from proteasomal degradation.&hellip;<span class="activity-read-more" id="activity-read-more-9311"><a href="https://toxicdolls.com/activity-2/p/9311/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">8ed3fd0f91da62dd75fefbc96d8699b0</guid>
				<title>Axelsen Levy became a registered member</title>
				<link>https://toxicdolls.com/activity-2/p/9239/</link>
				<pubDate>Mon, 23 Jun 2025 21:47:19 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>